Cancer is the second most costly medical condition in the United States behind heart disease, and a study presented at the American Society of Clinical Oncology (ASCO) sought to better understand Medicare costs.
Hospitals & Providers
Physician leader Atul Gawande believes that as treatment options proliferate for cancer care and other serious illnesses, it will create a new challenge: patient communication about quality of life.
A new RAND study uncovers significant differences between healthcare costs paid by privately insured patients and those paid out by Medicare.
What these healthcare industry disruptors are, and how they could impact cost and quality of care.
The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.